[HTML][HTML] Progress in survival in renal cell carcinoma through 50 years evaluated in Finland and Sweden

K Hemminki, A Försti, A Hemminki, B Ljungberg… - PLoS …, 2021 - journals.plos.org
survival experience in Finland and Sweden over a period of … 1987–1991 and then declined
to the starting level; after 2002patients had distant metastases and the mean tumor size was …

Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a …

B Ljungberg, P Sundqvist, P Lindblad… - … journal of urology, 2020 - Taylor & Francis
… to the Swedish National Population Register for overall survival … The present study in the
early TKI era, suggests that in a … -risk patients, since all had synchronous metastatic disease […

Overall survival improvement in patients with metastatic clear-cell renal cell carcinoma between 2000 and 2020: a retrospective cohort study

S Demasure, I Spriet, PR Debruyne, A Laenen… - Acta …, 2022 - Taylor & Francis
… (the cytokin era, which was in our study predominantly IFNa), … study including 4.217 Swedish
patients diagnosed with mRCC between 2002 and 2005, 2006 and 2008 or 2009 and 2012

Real-world cost-effectiveness of targeted therapy in metastatic renal cell carcinoma in Sweden: a population-based retrospective analysis

J Redig, J Dalén, U Harmenberg… - … and Research, 2019 - Taylor & Francis
Overall survival and factors influencing overall survival in this … treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous metastatic

[HTML][HTML] Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not

O Hemminki, N Perlis, J Bjorklund, A Finelli… - European urology open …, 2020 - Elsevier
… listed as a treatment option for metastatic renal cell carcinoma in … During this time period,
indications for surgery have remained … However, an ad hoc subgroup analysis suggested no OS …

Metastatic papillary renal cell carcinoma in the era of targeted therapy–a retrospective study from three European academic centres

M Stenman, M Staehler, B Szabados… - Acta …, 2019 - Taylor & Francis
… (n = 86) referred to three academic centres in Sweden and … The aim of the study was to
evaluate overall survival (OS) of … Moreover, for patients with synchronous metastases

Comparative survival associated with use of targeted vs nontargeted therapy in medicare patients with metastatic renal cell carcinoma

P Li, J Jahnke, AR Pettit, YN Wong… - JAMA Network …, 2019 - jamanetwork.com
… , 36 our subgroup analysis of patients who had undergone … 44 ; in our study, unadjusted
median overall survival for the … our study period, and a recent analysis found greater survival

[HTML][HTML] Clinical T1a Renal Cell Carcinoma, Not Always a Harmless Disease—A National Register Study

T Almdalal, P Sundqvist, U Harmenberg… - European Urology Open …, 2022 - Elsevier
… the Swedish Cancer Register where all patients with any cancermetastases in patients
treated with ablation versus those … Urology guidelines on renal cell carcinoma: the 2019 update

Inflammatory response markers and survival prediction in patients with renal cell carcinoma

A Mountzias, J Hultdin, J Hlodan… - … journal of urology, 2022 - Taylor & Francis
… being alive in the Swedish National Population Register. The last … The updated TNM
classification 2017 was used for tumour … The mean overall survival for alive patients were 9.5 …

Surgical outcomes for older patients with renal cell carcinoma and inferior vena cava thrombus

Y Ishiyama, T Kondo, H Tachibana, H Ishihara… - … Oncology: Seminars and …, 2022 - Elsevier
Overall survival in Swedish patients with renal cell carcinoma treated in the period 2002
to 2012: update of the RENCOMP study with subgroup analysis of the synchronous